Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Brian Sauer

Concepts (392)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Rheumatoid
42
2024
1167
6.080
 Why?
Antirheumatic Agents
24
2024
293
5.640
 Why?
Veterans
32
2023
1476
4.000
 Why?
Spondylitis, Ankylosing
5
2020
46
2.460
 Why?
Hyperkalemia
3
2023
24
2.360
 Why?
Veterans Health
8
2023
186
2.180
 Why?
United States Department of Veterans Affairs
12
2021
678
1.960
 Why?
Methotrexate
10
2021
260
1.850
 Why?
Spondylarthritis
3
2020
50
1.290
 Why?
Natural Language Processing
4
2023
95
1.260
 Why?
Registries
18
2024
2035
1.240
 Why?
Rheumatology
2
2020
118
1.220
 Why?
Drug-Related Side Effects and Adverse Reactions
5
2019
250
1.220
 Why?
Biological Products
6
2021
216
1.200
 Why?
Tumor Necrosis Factor-alpha
6
2024
1242
1.110
 Why?
Medication Adherence
4
2019
467
1.090
 Why?
Drug Substitution
3
2021
54
0.960
 Why?
Psoriasis
2
2015
102
0.880
 Why?
Aged
46
2024
23961
0.840
 Why?
Arthritis, Psoriatic
3
2019
21
0.840
 Why?
Lymphoma, Follicular
2
2021
40
0.840
 Why?
Sulfasalazine
3
2019
23
0.810
 Why?
Hydroxychloroquine
3
2019
58
0.780
 Why?
Misoprostol
1
2022
17
0.770
 Why?
HLA-B27 Antigen
3
2019
16
0.760
 Why?
Lung Diseases, Interstitial
6
2024
638
0.740
 Why?
Humans
97
2024
137585
0.740
 Why?
Middle Aged
47
2024
33479
0.730
 Why?
United States
31
2023
14841
0.700
 Why?
Databases, Factual
7
2018
1357
0.700
 Why?
Electronic Health Records
6
2023
1069
0.700
 Why?
Cohort Studies
16
2024
5742
0.680
 Why?
Rituximab
2
2021
176
0.670
 Why?
Infliximab
3
2016
111
0.660
 Why?
Practice Patterns, Physicians'
5
2019
1313
0.650
 Why?
Analgesics, Opioid
5
2020
1000
0.650
 Why?
Insurance Claim Review
2
2017
64
0.650
 Why?
Pharmaceutical Services
2
2019
83
0.640
 Why?
Buprenorphine
1
2023
173
0.630
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2022
350
0.620
 Why?
Algorithms
5
2020
1704
0.610
 Why?
Prostatic Neoplasms, Castration-Resistant
1
2019
51
0.610
 Why?
Arthritis
2
2021
95
0.610
 Why?
Treatment Outcome
19
2024
10811
0.600
 Why?
Datasets as Topic
1
2019
121
0.590
 Why?
Anemia, Iron-Deficiency
1
2019
58
0.590
 Why?
Male
54
2024
67762
0.590
 Why?
Severity of Illness Index
12
2023
2828
0.580
 Why?
Etanercept
2
2016
57
0.580
 Why?
Antineoplastic Agents, Immunological
1
2020
190
0.570
 Why?
Adalimumab
2
2016
48
0.570
 Why?
Iron
2
2021
313
0.560
 Why?
Kidney Failure, Chronic
1
2022
570
0.520
 Why?
Chronic Pain
3
2022
262
0.520
 Why?
Renal Insufficiency, Chronic
2
2021
617
0.500
 Why?
Computer Simulation
4
2020
978
0.490
 Why?
Female
49
2024
73304
0.490
 Why?
Terminology as Topic
1
2017
216
0.490
 Why?
Opioid-Related Disorders
1
2023
515
0.470
 Why?
Delivery of Health Care
2
2022
951
0.470
 Why?
Healthcare Common Procedure Coding System
1
2014
1
0.460
 Why?
Cross-Over Studies
1
2017
564
0.460
 Why?
Diabetes Mellitus
3
2024
1040
0.460
 Why?
Risk Factors
23
2024
10388
0.450
 Why?
Insurance, Pharmaceutical Services
2
2011
22
0.440
 Why?
Research Design
3
2020
1139
0.440
 Why?
Adipokines
3
2022
49
0.430
 Why?
Cytokines
5
2024
2085
0.420
 Why?
Narcotics
1
2013
52
0.410
 Why?
Models, Statistical
2
2017
669
0.410
 Why?
Ambulatory Care
2
2014
546
0.400
 Why?
Hospitalization
5
2021
2199
0.400
 Why?
Comparative Effectiveness Research
1
2013
152
0.390
 Why?
Utah
7
2013
69
0.390
 Why?
Potassium
2
2023
147
0.380
 Why?
Drug Prescriptions
2
2013
245
0.380
 Why?
Emergency Service, Hospital
3
2023
2069
0.380
 Why?
Remission Induction
3
2022
288
0.370
 Why?
Pharmaceutical Preparations
3
2022
179
0.370
 Why?
Medicine
1
2013
121
0.370
 Why?
Time Factors
11
2021
6828
0.360
 Why?
Drug Overdose
2
2012
347
0.360
 Why?
Proportional Hazards Models
8
2022
1266
0.360
 Why?
Carpal Bones
2
2021
14
0.350
 Why?
Decision Support Systems, Clinical
2
2012
226
0.350
 Why?
Health Services Accessibility
2
2019
986
0.350
 Why?
Disease Progression
2
2018
2757
0.330
 Why?
Inflammatory Bowel Diseases
1
2015
351
0.330
 Why?
Cardiovascular Diseases
8
2023
2111
0.330
 Why?
Potentially Inappropriate Medication List
2
2020
16
0.330
 Why?
Adiponectin
4
2024
244
0.320
 Why?
Retrospective Studies
18
2023
15657
0.320
 Why?
Practice Guidelines as Topic
2
2019
1587
0.320
 Why?
Quality Indicators, Health Care
1
2012
307
0.310
 Why?
C-Reactive Protein
4
2021
410
0.310
 Why?
Kaplan-Meier Estimate
3
2021
889
0.290
 Why?
Aged, 80 and over
13
2021
7635
0.290
 Why?
Risk Assessment
10
2021
3457
0.290
 Why?
Body Mass Index
6
2018
2389
0.280
 Why?
Incidence
9
2024
2804
0.280
 Why?
Pneumonia, Bacterial
2
2020
116
0.280
 Why?
Antibodies, Monoclonal
1
2014
1430
0.270
 Why?
Health Knowledge, Attitudes, Practice
2
2013
1329
0.270
 Why?
Prospective Studies
9
2024
7604
0.270
 Why?
ROC Curve
3
2019
554
0.270
 Why?
International Classification of Diseases
4
2023
135
0.260
 Why?
Arthrodesis
3
2021
30
0.250
 Why?
Multimorbidity
2
2023
47
0.250
 Why?
Managed Care Programs
1
2007
135
0.250
 Why?
Predictive Value of Tests
4
2020
2031
0.240
 Why?
Drug Utilization
2
2018
169
0.240
 Why?
Propensity Score
3
2020
294
0.240
 Why?
Drug Therapy, Combination
2
2019
1066
0.230
 Why?
Embryo, Nonmammalian
2
2005
167
0.230
 Why?
Patient Admission
1
2007
197
0.230
 Why?
Gene Targeting
1
2004
81
0.220
 Why?
Adult
16
2022
37929
0.220
 Why?
Alarmins
1
2024
26
0.220
 Why?
Data Mining
3
2023
116
0.220
 Why?
Interleukin-33
1
2024
50
0.220
 Why?
Regression Analysis
3
2018
1024
0.210
 Why?
Embryo, Mammalian
1
2004
232
0.210
 Why?
Wrist
2
2021
54
0.210
 Why?
Wrist Joint
2
2021
62
0.210
 Why?
Poisson Distribution
2
2017
75
0.200
 Why?
Neoplasms
5
2023
2671
0.200
 Why?
Follow-Up Studies
7
2021
5131
0.200
 Why?
Weight Loss
2
2018
787
0.190
 Why?
Diclofenac
1
2022
15
0.190
 Why?
Neurology
1
2024
113
0.190
 Why?
Stroke
2
2021
1120
0.190
 Why?
Rheumatic Diseases
1
2023
81
0.190
 Why?
Chemokines
2
2021
228
0.190
 Why?
Blood Sedimentation
2
2019
39
0.190
 Why?
Comorbidity
4
2023
1622
0.190
 Why?
Research Report
1
2022
83
0.190
 Why?
Confidence Intervals
2
2016
329
0.180
 Why?
Genetic Testing
1
2004
460
0.180
 Why?
Polymerase Chain Reaction
1
2004
1062
0.180
 Why?
Linear Models
3
2018
849
0.180
 Why?
Waldenstrom Macroglobulinemia
1
2021
14
0.170
 Why?
Multivariate Analysis
5
2018
1509
0.170
 Why?
Hospitals, Veterans
3
2018
252
0.170
 Why?
Communication
2
2024
879
0.170
 Why?
Maintenance Chemotherapy
1
2020
35
0.170
 Why?
Education, Medical
1
2024
266
0.170
 Why?
Prescription Drugs
2
2012
109
0.170
 Why?
Cyclophosphamide
2
2021
247
0.170
 Why?
Arthritis, Infectious
1
2021
69
0.160
 Why?
Stem Cells
1
2004
594
0.160
 Why?
Prosthesis-Related Infections
1
2021
95
0.160
 Why?
Pneumonia, Staphylococcal
1
2020
23
0.160
 Why?
SEER Program
1
2020
227
0.160
 Why?
Neoplasm Grading
1
2020
307
0.160
 Why?
Transferrin
1
2019
47
0.150
 Why?
Ferritins
1
2019
64
0.150
 Why?
Inappropriate Prescribing
1
2019
55
0.150
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2020
123
0.150
 Why?
Bipolar Disorder
1
2021
263
0.150
 Why?
Ranolazine
1
2018
25
0.150
 Why?
Angina, Stable
1
2018
17
0.150
 Why?
Area Under Curve
1
2019
314
0.140
 Why?
Coronary Artery Disease
2
2022
698
0.140
 Why?
Geriatrics
1
2019
98
0.140
 Why?
Drug Monitoring
2
2012
218
0.140
 Why?
Arthroplasty, Replacement, Hip
1
2021
177
0.140
 Why?
Methicillin-Resistant Staphylococcus aureus
2
2020
234
0.140
 Why?
Osteoarthritis
1
2020
185
0.140
 Why?
Professional Practice Location
1
2017
29
0.140
 Why?
Rheumatologists
1
2017
16
0.140
 Why?
Anti-Citrullinated Protein Antibodies
1
2019
115
0.140
 Why?
Random Allocation
1
2018
353
0.140
 Why?
Sacroiliitis
1
2017
6
0.140
 Why?
Heart Failure
2
2021
2236
0.140
 Why?
Longitudinal Studies
4
2023
2844
0.140
 Why?
Reverse Transcriptase Inhibitors
1
2018
84
0.140
 Why?
Calcium Channel Blockers
1
2018
167
0.140
 Why?
Brain Ischemia
1
2021
338
0.140
 Why?
Obesity, Abdominal
1
2017
48
0.140
 Why?
Feasibility Studies
2
2020
956
0.130
 Why?
Protease Inhibitors
1
2018
107
0.130
 Why?
Recovery of Function
1
2021
653
0.130
 Why?
Data Accuracy
1
2017
65
0.130
 Why?
Disability Evaluation
1
2018
290
0.130
 Why?
Neoplasm Metastasis
1
2019
658
0.130
 Why?
Population Surveillance
2
2012
482
0.130
 Why?
HIV Integrase Inhibitors
1
2018
70
0.130
 Why?
Bias
3
2013
218
0.130
 Why?
Risk Management
2
2007
93
0.130
 Why?
Leptin
3
2022
236
0.130
 Why?
Pain
1
2022
756
0.130
 Why?
Adverse Drug Reaction Reporting Systems
2
2007
77
0.130
 Why?
Travel
1
2017
130
0.130
 Why?
Precision Medicine
1
2020
429
0.130
 Why?
Forecasting
1
2018
389
0.130
 Why?
Prognosis
3
2020
4030
0.130
 Why?
Dose-Response Relationship, Radiation
1
2016
141
0.130
 Why?
Neoplasm Staging
1
2020
1389
0.130
 Why?
Adrenergic beta-Antagonists
1
2018
323
0.130
 Why?
Anti-Inflammatory Agents
2
2018
496
0.130
 Why?
Antimicrobial Stewardship
1
2018
118
0.120
 Why?
Fees, Pharmaceutical
1
2015
9
0.120
 Why?
Hypertension
2
2018
1295
0.120
 Why?
Drug Administration Routes
1
2015
38
0.120
 Why?
Cross-Sectional Studies
6
2024
5472
0.120
 Why?
Arthroplasty, Replacement, Knee
1
2021
363
0.120
 Why?
Observational Studies as Topic
1
2016
117
0.120
 Why?
Anti-Retroviral Agents
1
2018
233
0.120
 Why?
Anti-Infective Agents
1
2018
255
0.120
 Why?
Hospital Mortality
1
2020
911
0.120
 Why?
Cyclosporine
1
2016
268
0.120
 Why?
Cause of Death
4
2023
434
0.120
 Why?
Pseudomonas Infections
1
2017
225
0.120
 Why?
Logistic Models
2
2018
2074
0.120
 Why?
Health Care Costs
1
2018
398
0.120
 Why?
Recombination, Genetic
3
2005
204
0.110
 Why?
Obesity
2
2018
2992
0.110
 Why?
Cross Infection
1
2017
256
0.110
 Why?
Inflammation Mediators
1
2017
513
0.110
 Why?
Drug Administration Schedule
1
2016
786
0.110
 Why?
Suicide
1
2021
656
0.110
 Why?
Glucocorticoids
1
2018
594
0.110
 Why?
Quality Improvement
1
2022
1178
0.110
 Why?
Health Expenditures
1
2015
189
0.110
 Why?
Guideline Adherence
1
2018
556
0.110
 Why?
Infusions, Intravenous
1
2014
413
0.110
 Why?
Prednisone
3
2021
240
0.100
 Why?
Causality
1
2013
126
0.100
 Why?
Telemedicine
1
2022
862
0.100
 Why?
HIV Infections
2
2018
2836
0.100
 Why?
Integrases
3
2005
120
0.100
 Why?
Diagnosis, Dual (Psychiatry)
1
2012
36
0.100
 Why?
Adiposity
1
2017
518
0.100
 Why?
Education, Medical, Continuing
1
2013
127
0.100
 Why?
Root Cause Analysis
1
2012
7
0.100
 Why?
Feedback
2
2023
173
0.100
 Why?
Mortality
1
2015
362
0.100
 Why?
Socioeconomic Factors
2
2018
1289
0.100
 Why?
Pneumonia
1
2018
639
0.100
 Why?
Prescription Drug Misuse
1
2012
41
0.090
 Why?
Occupational Injuries
1
2012
44
0.090
 Why?
Florida
1
2012
107
0.090
 Why?
Lung Diseases
1
2018
767
0.090
 Why?
HIV-1
1
2018
864
0.090
 Why?
Lung Neoplasms
2
2022
2526
0.090
 Why?
Narration
1
2012
58
0.090
 Why?
Outpatients
1
2014
396
0.090
 Why?
Health Personnel
1
2017
710
0.090
 Why?
Osteoporotic Fractures
1
2012
60
0.090
 Why?
Internal Medicine
1
2013
265
0.090
 Why?
Risk
1
2013
912
0.090
 Why?
Antineoplastic Agents
1
2022
2129
0.090
 Why?
Adolescent
5
2015
21513
0.090
 Why?
Reproducibility of Results
2
2016
3284
0.080
 Why?
Dose-Response Relationship, Drug
1
2014
2057
0.080
 Why?
Substance-Related Disorders
2
2023
1083
0.080
 Why?
Anti-Bacterial Agents
1
2020
1809
0.080
 Why?
Young Adult
3
2015
13209
0.080
 Why?
Blood Pressure
2
2018
1786
0.080
 Why?
Pattern Recognition, Automated
1
2008
73
0.070
 Why?
Sex Factors
3
2021
2071
0.070
 Why?
Diagnosis, Computer-Assisted
1
2008
89
0.070
 Why?
Hospital Records
1
2007
12
0.070
 Why?
Cost Sharing
1
2007
15
0.070
 Why?
Financing, Personal
1
2007
26
0.070
 Why?
Catheter-Related Infections
1
2008
92
0.070
 Why?
Referral and Consultation
1
2013
786
0.070
 Why?
Antihypertensive Agents
1
2011
494
0.070
 Why?
Nonlinear Dynamics
1
2007
88
0.070
 Why?
Biomarkers
3
2024
4149
0.070
 Why?
Mutagenesis, Site-Directed
2
2005
375
0.060
 Why?
Insulin-Like Growth Factor I
2
1999
319
0.060
 Why?
Machine Learning
2
2022
493
0.060
 Why?
Viral Proteins
2
1999
342
0.060
 Why?
Primary Health Care
2
2013
1738
0.060
 Why?
Drug Interactions
1
2007
410
0.060
 Why?
Artificial Intelligence
1
2008
279
0.060
 Why?
Respiratory Tract Diseases
2
2017
184
0.060
 Why?
Models, Theoretical
1
2008
578
0.060
 Why?
Blotting, Southern
1
2004
73
0.060
 Why?
Health Services Research
1
2007
404
0.060
 Why?
Inpatients
2
2024
500
0.060
 Why?
Chronic Disease
2
2022
1793
0.060
 Why?
Data Collection
1
2007
673
0.060
 Why?
Mental Disorders
1
2012
1077
0.050
 Why?
Myocardial Infarction
1
2011
1046
0.050
 Why?
Interleukin-17
1
2024
119
0.050
 Why?
Mass Screening
1
2012
1287
0.050
 Why?
Health Status
2
2018
792
0.050
 Why?
Vital Capacity
1
2023
311
0.050
 Why?
Acetazolamide
1
2022
26
0.050
 Why?
Odds Ratio
2
2018
1070
0.050
 Why?
Telomere Shortening
1
2022
20
0.050
 Why?
Antimanic Agents
1
2021
18
0.050
 Why?
Medicare
1
2007
773
0.050
 Why?
Lithium
1
2021
43
0.050
 Why?
Length of Stay
1
2007
1215
0.050
 Why?
Valproic Acid
1
2021
48
0.050
 Why?
Chlorambucil
1
2021
10
0.040
 Why?
Medication Therapy Management
1
2022
76
0.040
 Why?
Vidarabine
1
2021
33
0.040
 Why?
Bendamustine Hydrochloride
1
2021
13
0.040
 Why?
Bortezomib
1
2021
54
0.040
 Why?
Patient Discharge
2
2023
897
0.040
 Why?
Pulmonologists
1
2020
14
0.040
 Why?
Zebrafish
1
2005
499
0.040
 Why?
Data Display
1
2020
21
0.040
 Why?
Vincristine
1
2021
116
0.040
 Why?
Cerebrovascular Circulation
1
2022
243
0.040
 Why?
Quality Control
1
2020
172
0.040
 Why?
Computed Tomography Angiography
1
2021
129
0.040
 Why?
Magnetic Resonance Imaging
2
2022
3566
0.040
 Why?
User-Computer Interface
1
2020
159
0.040
 Why?
Pharmacists
1
2022
265
0.040
 Why?
Embryonic and Fetal Development
1
1999
97
0.040
 Why?
Bone Marrow Transplantation
1
2020
286
0.040
 Why?
Range of Motion, Articular
1
2021
393
0.040
 Why?
Telomere
1
2022
280
0.040
 Why?
Piperidines
1
2021
206
0.040
 Why?
Magnetic Resonance Angiography
1
2021
240
0.040
 Why?
Doxorubicin
1
2021
362
0.040
 Why?
Adenine
1
2021
271
0.040
 Why?
Dexamethasone
1
2021
368
0.040
 Why?
Gene Dosage
1
1998
140
0.040
 Why?
Patient Satisfaction
1
2022
660
0.040
 Why?
Cost-Benefit Analysis
1
2020
591
0.030
 Why?
Time-to-Treatment
1
2019
205
0.030
 Why?
Reoperation
1
2020
573
0.030
 Why?
Methicillin Resistance
1
2017
18
0.030
 Why?
Infant Mortality
1
1998
116
0.030
 Why?
Recurrence
1
2020
1060
0.030
 Why?
Gene Expression Regulation, Developmental
2
1999
860
0.030
 Why?
HIV Integrase
1
2018
70
0.030
 Why?
Rheumatic Nodule
1
2016
3
0.030
 Why?
Cardiovascular Agents
1
2018
159
0.030
 Why?
Absorptiometry, Photon
1
2017
259
0.030
 Why?
Isoxazoles
1
2016
54
0.030
 Why?
Critical Illness
1
2022
811
0.030
 Why?
Thinness
1
2016
91
0.030
 Why?
Nutrition Surveys
1
2017
266
0.030
 Why?
Viral Load
1
2018
466
0.030
 Why?
Body Weight
2
2016
985
0.030
 Why?
Rheumatoid Factor
1
2016
175
0.030
 Why?
Survival Analysis
1
2018
1325
0.030
 Why?
Lymphoma
1
2016
208
0.030
 Why?
Community-Acquired Infections
1
2017
174
0.030
 Why?
Peptides, Cyclic
1
2016
259
0.030
 Why?
Analysis of Variance
1
2018
1316
0.030
 Why?
Surveys and Questionnaires
2
2020
5778
0.030
 Why?
Leukemia
1
2016
240
0.030
 Why?
Quality of Health Care
1
2018
642
0.030
 Why?
Age Factors
1
2021
3295
0.030
 Why?
Life Style
1
2016
490
0.030
 Why?
Tomography, X-Ray Computed
1
2023
2691
0.020
 Why?
Workers' Compensation
1
2012
27
0.020
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2021
1692
0.020
 Why?
Coroners and Medical Examiners
1
2011
8
0.020
 Why?
Inflammation
1
2022
2837
0.020
 Why?
Death Certificates
1
2011
30
0.020
 Why?
Sampling Studies
1
2011
99
0.020
 Why?
Brain
1
2022
2668
0.020
 Why?
Prostatic Neoplasms
1
2016
1043
0.020
 Why?
Smoking
1
2016
1627
0.020
 Why?
Pancreatic Neoplasms
1
2016
938
0.020
 Why?
Medical Assistance
1
2007
12
0.020
 Why?
Models, Econometric
1
2007
34
0.020
 Why?
Psychoses, Substance-Induced
1
2007
13
0.020
 Why?
Deductibles and Coinsurance
1
2007
13
0.020
 Why?
Quality of Life
1
2019
2892
0.020
 Why?
Eligibility Determination
1
2007
65
0.020
 Why?
Evidence-Based Medicine
1
2011
740
0.020
 Why?
Costs and Cost Analysis
1
2007
213
0.020
 Why?
Child
1
2007
21935
0.020
 Why?
Delirium
1
2007
92
0.020
 Why?
Insurance Coverage
1
2007
230
0.020
 Why?
Blood Coagulation Disorders
1
2007
173
0.010
 Why?
beta-Galactosidase
1
2005
78
0.010
 Why?
HSP70 Heat-Shock Proteins
1
2005
73
0.010
 Why?
Mosaicism
1
2005
73
0.010
 Why?
Genes, Reporter
1
2005
269
0.010
 Why?
Animals, Genetically Modified
1
2005
240
0.010
 Why?
Sensitivity and Specificity
1
2008
1946
0.010
 Why?
Mice, Transgenic
2
1999
2167
0.010
 Why?
Case-Control Studies
1
2011
3556
0.010
 Why?
Hemorrhage
1
2007
722
0.010
 Why?
Recombinant Fusion Proteins
1
2005
665
0.010
 Why?
Liver
2
1999
1943
0.010
 Why?
Growth Disorders
1
1998
86
0.010
 Why?
Animals
3
2005
36940
0.010
 Why?
Mice
2
1999
17787
0.010
 Why?
RNA, Messenger
1
1998
2833
0.010
 Why?
Infant, Newborn
1
1998
6079
0.000
 Why?
Sauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (392) concept(s)
_
Co-Authors Expand Description
See all (18) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)